The global orthopedic soft tissue repair market size was valued at USD 6.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. Increasing incidence of soft tissue injuries due to growth in the aging population, obesity rate, sports and physical activity injuries, and trauma accidents is likely to propel market growth over the forecast period. In addition, innovations in new therapies and devices, growing R&D activities, and increasing healthcare awareness and per capita expenditure with a lack of substitutes for soft tissue repair therapies, are other factors expected to drive the demand for orthopedic soft tissue repair therapies. The introduction of new developing technologies, such as biological meshes, bioprinting, and biofabrication, is also expected to bolster market growth. For instance, CoNextions TR by CoNextions Medical provides a fast surgical process, stronger repair strength, and quicker patient recovery as compared to current suture-approach repair procedures.
The surge in the incidence of sports-related injuries along with rapid growth in the number of athletes is key impact-rendering drivers for the market over the forecast period. Sports activities are the leading cause of soft tissue injuries worldwide. Athletes are prone to ACL injuries, which can hinder their mobility. According to an emergency room visits survey conducted by Safe Kids Worldwide, young athletes visit hospital emergency rooms for sports-related injuries more than a million times a year. Rising career opportunities and growing inclination toward fitness, owing to growing health awareness have increased the number of people choosing sports as a hobby or a career. It, in turn, is expected to increase their chances of incurring injuries. For instance, according to the Standard Children’s Health, in the U.S., out of 30 million children and teens participating in sports, about 3.5 million incur injuries.
Improvement of life expectancy has led to an increase in the geriatric population, which is expected to grow significantly in the future. Aging causes critical changes in the skeletal and neuromuscular systems, which may lead to arthritis, weakened ligaments, and ACL tears. An increase in the geriatric population has led to a rise in global demand for orthopedic soft tissue repair surgeries. Currently, the geriatric population is growing rapidly. As per the Population Reference Bureau, in July 2019, the number of Americans aged 65 years, or more is projected to double from an estimated 52 million in 2018 to 95 million by 2060. The overall population aged 65 years and above is anticipated to rise from 16% to 23%. Therefore, the need for acute and long-term healthcare services is increasing, which is expected to drive the market for orthopedic soft tissue repair.
Rising awareness about orthopedic soft tissue repairs is another factor responsible for significant market growth. Neuromuscular training programs are being conducted for athletes, which are expected to significantly help in reducing the risk of ACL tears and other injuries. In addition, increasing awareness about osteoporosis, which is the most common disorder in the population aged over 70 years, is also increasing. As per International Osteoporosis Foundation, the total number of hip fractures is expected to increase from 1.66 million in 1990 to 6.26 million in 2050. The growing prevalence of this disorder can lead to an increase in economic burden for various countries, thereby propelling market growth.
Post COVID Outlook
The orthopedic soft tissue repair market decreased by 1.1% from 2019 to 2020
The market is estimated to witness a y-o-y growth of approximately 6.7% to 7.1% in the next 5 years
Factors such as shortage of Personal Protective Equipment (PPE) and trained workforce and restrictions and lockdowns forced the healthcare facilities to reschedule and prioritize procedures as essential or nonessential. During this pandemic, several orthopedic surgeries were considered essential, which can be attributed to the significant market size.
The healthcare facilities are focused on developing strategies to restart elective orthopedic surgeries once the pandemic stabilizes. Moreover, management of delayed orthopedic-related trauma conditions is a profound task by the evolving healthcare facilities.
The pandemic affected manufacturing, supply chains, product distribution, operations, and other business activities of the key players. Various companies operating in the market have reported a decline in sales of their orthopedic soft tissue repair products.
The healthcare facilities are focused on mitigating ley logistical challenges under the guidance of various health care organizations such as WHO, CDC, American college of surgeons. In addition, the orthopedic community is focused on providing the best care for patients in post-acute COVID-19 stages, thereby providing affirmative growth prospects in the coming years.
Furthermore, increasing investments in R&D, collaborations with other industry players, geographic expansions, and product differentiation are among the key strategies adopted by key companies for gaining a competitive edge in the market. For instance, in December 2020, Zimmer Biomet acquired A&E Medical, a provider of sternal closure devices. This acquisition was expected to strengthen the former’s portfolio of sternal closure products and rigid fixation devices, enabling it to cater to the unmet needs of patients and clinicians.
The application segment consists rotator cuff repair, epicondylitis, Achilles tendinosis repair, pelvic organ prolapse, gluteal tendon repair, cruciate ligaments repair, hip arthroscopy, biceps tendinosis, and others. In 2022, cruciate ligaments repair accounted for the largest market share of 40.2%. The growth is attributed to the increasing incidence of ACL injuries during sporting activities. Soccer and baseball players commonly suffer such types of injury. According to the American Journal of Sports Medicine, the incidence of ACL injury is 68.6/100,000 individuals per year. The increase in the number of sports activities is leading to a rise in the number of sports injuries among athletes, which is further propelling the demand for improved orthopedic soft tissue repair products. As per our estimates in 2018, nearly 399,431 reconstruction procedures were carried out in the U.S., and the number is expected to reach 787,463 by 2025.
This segment is further anticipated to register the fastest growth with a CAGR of 8.9% during the forecast period. Injuries to the ACL account for 40% to 50% of all knee ligament injuries. Increasing incidence of knee injuries and the introduction of innovative and technologically advanced products, which are cost-effective and patient-friendly, are among the major factors likely to drive the adoption of these surgeries. Moreover, an increase in awareness about potential threats of developing arthritis from uncorrected ACL tears and injuries is expected to push patients to opt for either invasive or minimally invasive surgeries.
The injury location segment consists of knee shoulder, hip, and small joints. In 2022, the knee application segment held the largest market share of 38.9%. This growth is owing to the greater applicability and acceptability of orthopedic soft tissue repair surgeries and increasing adoption of treatment options in developed and emerging countries. Soft tissue knee injuries are one of the most common musculoskeletal disorders, with the increasing prevalence of knee tissue tears, wear downs or impairments related to sports injuries, age-related issues, trauma, and accidents. In addition, the acceptance and affordability of available treatment options are expected to further drive market growth. In the Global Burden of Diseases (GBD) study of 2017, the impact of musculoskeletal injuries accounted for 16% of all years lived with disability, making it the highest contributor to the global disability index.
However, the hip application segment is anticipated to register the fastest growth with a CAGR of 8.8% during the forecast period. Its rapid growth can be attributed to the increasing incidence of hip joint dysfunction caused by soft tissue injuries. Soft tissue injuries surrounding the hip joint may result in joint dysfunction. Some of the focus areas for hip pathology over the recent years included impingement in the hip and hip labrum tears. With increasing incidences of labral tears, chondral damage, and ligamentum teres lesions of deep soft tissues in the hips, which cannot be corrected or treated effectively with physiotherapy, this segment is gaining attention and driving market players to innovate devices and therapies to provide adequate treatment.
North America accounted for the largest market share of 45.0% in 2022 due to the growing number of knee arthroscopies performed in the region. For instance, as per an article published by the Osteoarthritis Research Society International, out of 1 million knee arthroscopies performed annually in the U.S., 700,000 of them involved the meniscus. Another key factor driving the regional growth is attributed to rising healthcare expenditure and investments in healthcare infrastructure as an increase in healthcare spending can help make expensive orthopedic soft tissue repair surgeries more affordable. For instance, according to NHE data demonstrated by KFF, the total national health expenditure of the U.S. increased from USD 3,178 billion in 2015 to USD 3,795 billion in 2019.
However, Asia Pacific is anticipated to register the fastest growth with a CAGR of 9.7% during the forecast period owing to the increasing prevalence of musculoskeletal disorders and rising disposable income. Higher penetration of local manufacturers of medical devices is providing significant growth opportunities for the market in the region. Furthermore, the other key factors driving the market are ongoing research in this field, particularly in Japan and India, and the large geriatric population at risk of musculoskeletal disorders. For instance, Japan is considered to be the country with the highest geriatric population in the region.
The market is fragmented in nature, with the presence of a large number of companies. This, in turn, is increasing competition in the market for orthopedic soft tissue repair. Key companies are undergoing the formation of multiple partnerships and MnA to increase their product portfolio, as well as, to expand their footprint across new regions. In addition, companies are focusing on product differentiation and bundling strategies to capture a greater market share. In January 2021, Smith & Nephew acquired the Extremity Orthopedics business from Integra LifeSciences Holdings Corporation for USD 240 million. This acquisition was expected to bolster the extremities segment’s growth, as well as shoulder replacement and foot and ankle segments. Some of the prominent players in the orthopedic soft tissue repair market include:
DePuy Synthes, Inc.
Wright Medical Group N.V.
Integra LifeSciences Holding Corporation
Smith & Nephew
Market size value in 2023
USD 6.8 billion
Revenue forecast in 2030
USD 11.9 billion
CAGR of 8.3% from 2023 to 2030
Base year for estimation
2016 - 2021
2023 - 2030
Revenue in USD million and CAGR from 2023 to 2030
Revenue, company ranking, competitive landscape, growth factors, and trends
Application, injury location, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; Germany; U.K.; Spain; Italy; France; Russia; Japan; China; India; Australia; South Korea; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE
Key companies profiled
Arthrex, Inc.; DePuy Synthes, Inc.; Stryker; Wright Medical Group N.V.; Zimmer Biomet; CONMED Corporation; Integra LifeSciences Holding Corporation; Smith & Nephew
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global orthopedic soft tissue repair market report on the basis of application, injury location, and region:
Application Outlook (Revenue, USD Million, 2016 - 2028)
Rotator Cuff Repair
Achilles Tendinosis Repair
Pelvic Organ Prolapse
Gluteal Tendon Repair
Cruciate Ligaments Repair
Injury Location Outlook (Revenue, USD Million, 2016 - 2028)
Regional Outlook (Revenue, USD Million, 2016 - 2028)
b. The global orthopedic soft tissue market size was estimated at USD 6.6 billion in 2022 and is expected to reach USD 6.8 billion in 2023.
b. The global orthopedic soft tissue repair market is expected to grow at a compound annual growth rate of 8.3% from 2023 to 2030 to reach USD 11.9 billion by 2030.
b. The cruciate ligaments repair segment dominated the orthopedic soft tissue repair market with a share of 40.2% in 2022.
b. Some key players operating in the orthopedic soft tissue repair market include Stryker, Arthrex, Inc., Zimmer Biomet, DePuy Synthes, Inc, CONMED Corporation, and Smith & Nephew plc.
b. Key factors that are driving the orthopedic soft tissue repair market growth include a rise in the number of sports-related injuries and growth in the aging population, obesity rate, and trauma & accidents.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."